Document Detail


EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2.
MedLine Citation:
PMID:  19838702     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
These guidelines summarize the current views of the European Association of Nuclear Medicine Neuroimaging Committee (ENC). The aim of the guidelines is to assist nuclear medicine practitioners when making recommendations, performing, interpreting, and reporting the results of clinical dopamine transporter (DAT) single photon emission computed tomography (SPECT) studies using (123)I-labelled radiopharmaceuticals. The aim is to achieve a high-quality standard of DAT SPECT imaging, which will increase the diagnostic impact of this technique in neurological practice. The present document is an update of the 2002 guidelines [1] and has been guided by the views of various national societies: the Task Group Neuro-Nuclear-Medicine of the German Society of Nuclear Medicine [2], a consensus statement of the imaging centres included in the "Kompetenznetz-Parkinson" sponsored by the German Federal Ministry of Education, and the Task Group of Neuro-Nuclear-Medicine of the French Society of Nuclear Medicine [3]. The guidelines reflect the individual experience of experts in European countries. The guidelines are intended to present information specifically adapted to European practice. The information provided should be taken in the context of local conditions and regulations.
Authors:
Jacques Darcourt; Jan Booij; Klaus Tatsch; Andrea Varrone; Thierry Vander Borght; Ozlem L Kapucu; Kjell Någren; Flavio Nobili; Zuzana Walker; Koen Van Laere
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of nuclear medicine and molecular imaging     Volume:  37     ISSN:  1619-7089     ISO Abbreviation:  Eur. J. Nucl. Med. Mol. Imaging     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-02-04     Completed Date:  2010-05-06     Revised Date:  2011-04-20    
Medline Journal Info:
Nlm Unique ID:  101140988     Medline TA:  Eur J Nucl Med Mol Imaging     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  443-50     Citation Subset:  IM    
Affiliation:
University Hospital, Université de Nice Sophia Antipolis, Nice, France. darcourt@unice.fr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Brain / metabolism*,  radionuclide imaging*
Dopamine / diagnostic use*,  pharmacokinetics*
European Union
Female
Humans
Male
Positron-Emission Tomography / standards*
Practice Guidelines as Topic*
Radiopharmaceuticals / diagnostic use,  pharmacokinetics
Receptors, Dopamine D2 / metabolism*
Synaptic Transmission / physiology
Tomography, Emission-Computed, Single-Photon / standards*
Chemical
Reg. No./Substance:
0/Radiopharmaceuticals; 0/Receptors, Dopamine D2
Comments/Corrections
Comment In:
Eur J Nucl Med Mol Imaging. 2011 Apr;38(4):786-7   [PMID:  21274529 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR (111)In-D...
Next Document:  EANM procedure guideline for brain perfusion SPECT using (99m)Tc-labelled radiopharmaceuticals, vers...